(1.01%) 5 069.23 points
(0.95%) 38 264 points
(1.56%) 15 848 points
(0.16%) $79.13
(5.69%) $2.04
(0.26%) $2 317.00
(0.78%) $26.96
(1.10%) $965.45
(-0.10%) $0.932
(-0.39%) $10.99
(-0.10%) $0.798
(-1.37%) $91.98
@ $14.23
Išleistas: 12 vas. 2024 @ 16:30
Grąža: -25.65%
Ankstesnis signalas: vas. 8 - 21:14
Ankstesnis signalas:
Grąža: -8.66 %
Live Chart Being Loaded With Signals
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients...
Stats | |
---|---|
Šios dienos apimtis | 46 014.00 |
Vidutinė apimtis | 134 600 |
Rinkos kapitalizacija | 192.39M |
EPS | $0 ( 2024-03-28 ) |
Kita pelno data | ( $-0.110 ) 2024-05-14 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -10.27 |
ATR14 | $0.0170 (0.16%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-15 | Febbo William J | Buy | 15 000 | Common Stock |
2024-02-15 | Besch Doug | Buy | 4 000 | Common Stock |
2024-02-15 | Odence-ford Marion | Buy | 4 267 | Common Stock |
2024-02-15 | Stelmakh Edward | Buy | 7 083 | Common Stock |
2024-03-15 | Silvestro Stephen L | Buy | 7 750 | Common Stock |
INSIDER POWER |
---|
64.96 |
Last 99 transactions |
Buy: 688 413 | Sell: 153 496 |
Tūris Koreliacija
OPTIMIZERx Corp Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
OPTIMIZERx Corp Koreliacija - Valiuta/Žaliavos
OPTIMIZERx Corp Finansinės ataskaitos
Annual | 2023 |
Pajamos: | $71.52M |
Bruto pelnas: | $42.90M (59.98 %) |
EPS: | $-1.030 |
FY | 2023 |
Pajamos: | $71.52M |
Bruto pelnas: | $42.90M (59.98 %) |
EPS: | $-1.030 |
FY | 2022 |
Pajamos: | $62.45M |
Bruto pelnas: | $38.97M (62.40 %) |
EPS: | $-0.600 |
FY | 2021 |
Pajamos: | $61.29M |
Bruto pelnas: | $35.64M (58.14 %) |
EPS: | $0.0214 |
Financial Reports:
No articles found.
OPTIMIZERx Corp
OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.